| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V0017 | NSC 319726 | 71555-25-4 | NSC319726 is a novel and potent p53(R175) mutant reactivator with with potential anticancer activity. |
|
V0020 | Pifithrin-μ (NSC-303580) | 64984-31-2 | Pifithrin-μ (NSC303580) is a novel and potent inhibitor of p53 binding and p53-mediated apoptosis with a Kd of 0.82 mM in vitro. |
|
V4115 | Kevetrin HCl | 66592-89-0 | Kevetrinhydrochloride (also known as thioureidobutyronitrile; 4-Isothioureidobutyronitrile hydrochloride; thioureidobutyronitrile hydrochloride; thioureido butyronitrile hydrochloride), is a water-soluble, small molecule activator of the tumor suppressor protein p53. |
|
V76056 | Anticancer agent 68 | 2692652-36-9 | Anticancer agent 68 is (Compound 12) is an anticancer agent. |
|
V129295 | Apoptosis inducer 56 | 952306-31-9 | Apoptosis inducer 56 is an apoptosis inducer. |
|
V88505 | CDK2/MDM2-IN-1 | CDK2/MDM2-IN-1 (III-13) is a CDK2/MDM2 dual inhibitor with IC50 of 2.60 nM for CDK2. | |
|
V131849 | CK2-TN03 | 313226-24-3 | CK2-TN03 is an ATP-competitive casein kinase 2 (CK2) inhibitor with an IC50 of 165 nM and a Ki of 20 nM. |
|
V3174 | COTI-2 | 1039455-84-9 | COTI-2 is an orally available, 3rd generation small molecule activator of the mutant p53 protein (a tumor suppressor). |
|
V0021 | MI-773 (2'S,3R isomer, SAR-405838) | 1303607-60-4 | MI-773 (2S,3R isomer, SAR405838) is a novel, potent, specific and orally bioavailable small molecule antagonist of MDM2/piro-oxindole HDM2 (Murine double minute 2/human double minute 2) with a Ki value of 0.88 nM. |
|
V80841 | MS78 | MS78 is an acetylation-targeting chimera (AceTAC) that acetylates the p53 tumor suppressor protein. | |
|
V0016 | Tenovin-1 | 380315-80-0 | Tenovin-1, a small molecule compound discovered by a cell-based screen, is a novel and potent activator of p53 that protects against MDM2-mediated p53 degradation. |
|
V0018 | NSC59984 | 803647-40-7 | NSC59984 is a novel and potent activator of p53 with potential anticancer activity. |
|
V141720 | NVP-CFC218 | 1313363-06-2 | NVP-CFC218 is a selective TP53-MDM2 inhibitor with similar structure and biochemical properties to NVP-CGM097 (IC50 of 1.6 nM: displacing p53 peptide from the surface of HDM2). |
|
V88518 | PNC-27 acetate | PNC-27 acetate is a chimeric p53-penetrating peptide that binds to HDM-2 in a p53 peptide-like structure, inducing selective membrane pore formation and leading to cancer cell lysis. | |
|
V144061 | Rezatapopt analog-2 | 2636847-09-9 | Rezatapopt analog-2 is an analogue of Rezatapopt that can be combined with P53. |
|
V0015 | RITA (NSC 652287) | 213261-59-7 | RITA (also known as NSC-652287) is a novel and potent inhibitor of p53-HDM-2 protein-protein interaction with potential anticancer activity. |
|
V12467 | SCH529074 | 922150-11-6 | SCH529074 is an orally bioactive p53 activator. |
|
V105065 | Seldegamadlin (KT-253) | 2713618-08-5 | KT-253 is a p53 stabilizer and PROTAC degrader of MDM2 (DC50=0.4 nM). |
|
V144772 | SEN205A | 958712-85-1 | SEN205A is a fragment compound that can bind to the hydrophobic pocket (Kd = 0.5-1.0 mM) of human S100B, which is a key region for the interaction of S100B with TRTK-12 and p53. SEN205A can be displaced from this site by TRTK-12. |
|
V144971 | Siremadlin succinate | 1638193-48-2 | Siremadlin succinate is an MDM2 inhibitor and cell cycle regulator. |